Carbohydrates and nucleosides
for pharmaceutical applications
From custom synthesis to cGMP manufacturing
Custom synthesis
and related services
Get in touch
cGMP & CDMO
We help pharmaceutical companies to compress time-to-market by providing integrated contract development and manufacturing services.
Our expertise in complex carbohydrate and nucleoside synthesis is unrivalled on a global scale, and we can design efficient and effective processes to produce your carbohydrate or nucleoside-based pharmaceutical ingredients.
Our modern and versatile facilities allow us to be flexible and customise projects to your requirements.
We have a GMP-certified plant based in Switzerland, with qualified clean room labs, production and filling facilities.
Our CDMO services include:
- Process development
- Analytical development
- Route scouting
- Pilot manufacturing
- Scale-up
- Management of outsourcing activities
- Quality assurance
- Regulatory support
Get in touch
Supporting research and development of SARS-CoV-2 therapeutics and vaccines
Small molecules
- Inhibitors of viral proteases
- Inhibitors of viral RNA-dependent RNA polymerase (RdRp)
- Anti-inflammatory compounds
- Natural products with antiviral activity
Enzymes
- Main protease (Mpro) from SARS-CoV-2
Structural proteins
- Spike glycoprotein
- Nucleoprotein